title: [Pharmacological concepts for the treatment of obesity - a therapeutic meander?].
authors.affiliation: Institut für Klinische Pharmakologie, Medizinische Fakultät der TU Dresden. christoph.schindler@tu-dresden.de
authors.forename: C
authors.initials: C
authors.lastname: Schindler
authors.forename: T
authors.initials: T
authors.lastname: Chavakis
authors.forename: V
authors.initials: V
authors.lastname: Lamounier-Zepter
authors.forename: S R
authors.initials: SR
authors.lastname: Bornstein
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D001067:Appetite Depressants / Q000009:adverse effects / Q000627:therapeutic use*; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D003131:Combined Modality Therapy; D003503:Cyclobutanes / Q000009:adverse effects / Q000627:therapeutic use; D004038:Diet, Reducing; D017277:Drug Approval; D004338:Drug Combinations; D056736:Drug Recalls; D015507:Drugs, Investigational / Q000009:adverse effects / Q000627:therapeutic use; D005544:Forecasting; D006801:Humans; D009765:Obesity / Q000188:drug therapy*; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use; D011720:Pyrazoles / Q000009:adverse effects / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D000077285:Rimonabant
chemical_list: D001067:Appetite Depressants; D003503:Cyclobutanes; D004338:Drug Combinations; D015507:Drugs, Investigational; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant; C058254:sibutramine